Biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) reported Friday a net income attributable to common shareholders for the fourth quarter of $27.49 million or $1.18 per share, compared to a net loss of $10.68 million or $0.55 per share in the prior-year quarter.
Excluding items, adjusted earnings for the quarter were $2.33 per share, compared to $1.63 per share in the year-ago quarter.
Total net revenues for the quarter grew 29.6 percent to $247.06 million from $190.57 million in the same quarter last year.
Looking ahead to fiscal 2026, the company continues to project adjusted earnings in the range of $8.83 to $9.34 per share on net revenues between $1.055 billion and $1.115 billion.
In Friday's pre-market trading, ANIP is trading on the Nasdaq at $83.00, up $5.85 or 7.58 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
August 21, 2026 14:42 ET The minutes of the latest policy meeting of the Federal Reserve, housing market data and manufacturing sector survey results were the main news for the U.S. economy this week. In Europe, inflation data from the U.K. was the highlight, while consumer price data from Japan drew attention in Asia.